Table 2.

Prevalence of Colorectal Polyps according to Clinical Features in the Study

		All subjects	AN (n=118)		SSL (n=295)		Adenoma (n=1238)		HP (n=786)		Others (n=91)
				P-value		P-value		P-value		P-value		P-value
FIT, n (%)	Negative	1370 (56.2)	63 (4.6)	0.568	159 (11.6)	0.416	711 (51.9)	0.221	451 (32.9)	0.432	50 (3.6)	0.83
	TCS-only	1067 (43.8)	55 (5.2)		136 (12.7)		527 (49.4)		335 (31.4)		41 (3.8)
Sex, n (%)	Male	1250 (51.3)	84 (6.7)	<0.001	159 (12.7)	0.352	761 (60.9)	<0.001	465 (37.2)	<0.001	57 (4.6)	0.032
	Female	1187 (48.7)	34 (2.9)		136 (11.5)		477 (40.2)		321 (27)		34 (2.9)
Age group (years), n (%)	49–54	1254 (51.5)	45 (3.6)	0.003	153 (12.2)	0.901	573 (45.7)	<0.001	381 (30.4)	0.046	38 (3)	0.069
	55–60	1183 (48.5)	73 (6.2)		142 (12)		665 (56.2)		405 (34.2)		53 (4.5)
Smoking, n (%)	Never	1279 (52.5)	43 (3.4)	<0.001	129 (10.1)	0.001	555 (43.4)	<0.001	329 (25.7)	<0.001	44 (3.4)	0.455
	Current or past	1158 (47.5)	75 (6.5)		166 (14.3)		683 (59)		457 (39.5)		47 (4.1)
Alcohol, n (%)	Non-drinker	2140 (87.8)	105 (4.9)	0.774	255 (11.9)	0.448	1060 (49.5)	0.001	657 (30.7)	<0.001	79 (3.7)	0.329
	Drinker	297 (12.2)	13 (4.4)		40 (13.5)		178 (59.9)		129 (43.4)		12 (4)
BMI, kg/m2, median (IQR)		23.4(21.3–25.8)	24.3(22.4–25.8)	0.022	23.8(21.3–26.4)	0.375	23.9(21.8–26.1)	<0.001	24(21.9–26.6)	<0.001	24.8(22.9–27.2)	<0.001
Family history of CRC, n (%)	Yes	288 (11.8)	24 (8.3)	0.008	41 (14.2)	0.248	153 (53.1)	0.415	90 (31.3)	0.737	12 (4.2)	0.622
	No	2149 (88.2)	94 (4.4)		254 (11.8)		1085 (50.5)		696 (32.4)		79 (3.7)

FIT, fecal immunochemical test; BMI, body mass index; IQR, interquartile range; CRC, colorectal cancer; TCS, total colonoscopy; AN, advanced neoplasm; SSL, sessile serrated lesion; HP, Hyperplastic polyp